When can the tech industry credibly claim that artificial intelligence has made a scientific discovery? That question moved front and center last week after Anthropic announced that its Claude agents had identified a new biological pattern in a molecular biology lab. The claim quickly drew sharp pushback from scientists who say the finding was neither novel nor a true discovery.
Anthropic's Bold Claim
Anthropic announced last Wednesday that its Claude agents had made the company's first discovery inside a newly launched molecular biology lab. The system of 950 agents spent 21 hours combing through millions of DNA sequences and flagged a repeating pattern surrounding a known enzyme. Anthropic described the pattern as previously uncatalogued and likened its potential significance to the early observations that led to CRISPR gene editing. The company presented this as evidence that AI can now drive scientific progress autonomously.
The Biology Community Responds
But the response from biologists was swift and skeptical. A viral post from one researcher, later endorsed by the chair and CEO of drugmaker Eli Lilly, stated that identifying a genetic pattern is often the easy part. "The hard part, and where the real discoveries come from, is figuring out what the system actually does," the post read. The agents performed laboratory grunt work, the scientist argued, not a discovery.
Muddling the picture further, Mario Rodríguez Mestre, a biologist at the University of Copenhagen, told the New York Times that his team had already found the same pattern. Mestre, who regularly used Claude in his own research, questioned whether Anthropic had drawn from his conversations with the AI. Anthropic denies this, but Mestre said he has stopped using Claude entirely. The situation underscores how easily AI-assisted work can blur the line between discovery and routine analysis.
Why This Matters
The clash over Anthropic's announcement has consequences beyond one lab. AI companies are increasingly positioning their systems as autonomous discoverers rather than tools. This framing shifts expectations and risks eroding trust in genuine AI-assisted research. When the bar is set by corporate press releases rather than peer review, every real breakthrough may be met with skepticism. The incident follows a similar pattern with OpenAI, which earlier this month claimed its agents solved a major math problem, only to face questions about whether the problem was the one mathematicians actually cared about. The pattern is clear: the more AI companies claim discovery, the harder it becomes for the scientific community to assess what is actually new.
The question of when an AI can be said to have made a discovery has not been answered by Anthropic's announcement. But it has forced a necessary conversation about standards. As Lucas Harrington, the biologist who critiqued Anthropic's announcement, suggested, AI companies should "set the bar high now, so that when an AI actually discovers a fundamentally new biological mechanism, everyone appreciates how big a deal it is." The risk is that in a race to claim wins, companies like Anthropic and OpenAI will only make that appreciation harder to achieve.



